MFS
ATHE

MSI Financial Services’s Alterity Therapeutics ATHE Stock Holding History

MSI Financial Services’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Hold
50
– – ﹤0.01% 3625
2016
Q3 		$2K Hold
50
– – ﹤0.01% 3462
2016
Q2 		$2K Hold
50
– – ﹤0.01% 3471
2016
Q1 		$1K Hold
50
– – ﹤0.01% 3701
2015
Q4 		$2K Buy
+50
New +$2.54K ﹤0.01% 3404

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

MSI Financial Services's ATHE Position: Q4 2016 in Review

MSI Financial Services held its Alterity Therapeutics (ATHE) position steady in Q4 2016 at 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3625.

MSI Financial Services first reported a position in ATHE in Q4 2015 and has held it in 5 quarters since. The position peaked at $2K in Q3 2016. 17 funds tracked by Wall St. Rank hold ATHE as of Q4 2016.

  • MSI Financial Services held 50 shares of Alterity Therapeutics worth $1K as of Q4 2016.
  • MSI Financial Services left its Alterity Therapeutics share count unchanged in Q4 2016.
  • Alterity Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3625 holding.
  • MSI Financial Services first reported a position in Alterity Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Alterity Therapeutics position peaked at $2K in Q3 2016.
  • 17 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.